Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 2:34 PM
Ignite Modification Date:
2025-12-25 @ 1:06 PM
NCT ID:
NCT02551159
Group ID:
EG000
Title:
Durvalumab + Tremelimumab
Description:
tremelimumab (75 mg) via IV infusion every 4 weeks for a maximum of 4 doses, and durvalumab (1500 mg) via IV infusion every 4 weeks until disease progression
Deaths Number Affected:
356
Deaths Number At Risk:
None
Serious Number Affected:
168
Serious Number At Risk:
408
Other Number Affected:
317
Other Number At Risk:
408
Study:
NCT02551159
Results Section:
NCT02551159
Adverse Events Module:
NCT02551159